Neuroprotective effects of adenosine in cerebral ischemia: Window of opportunity

Neuroscience and Biobehavioral Reviews

Volumn 21, Issue 2, 1997, Pages 207-217

  Sweeney, Marva Irene ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Adenosine deaminase inhibitors; Adenosine receptor desensitization; Adenosine uptake inhibitors; Delayed neuronal death; Endogenous adenosine; Hypoxic pre conditioning; Ischemia; Side effects Brain; Stroke

Indexed keywords

8 (4 SULFOPHENYL)THEOPHYLLINE; 9 (2 HYDROXY 3 NONYL)ADENINE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE DEAMINASE INHIBITOR; ADENOSINE RECEPTOR BLOCKING AGENT; DIPYRIDAMOLE; NITROBENZYLTHIOINOSINE; PENTOSTATIN; PROPENTOFYLLINE;

ANIMAL MODEL; ARTICLE; BRAIN HYPOXIA; BRAIN ISCHEMIA; BRAIN PROTECTION; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG MECHANISM; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; STROKE;

ADENOSINE; ANIMALS; BRAIN ISCHEMIA; NEURONS; NEUROPROTECTIVE AGENTS;

EID: 0031041265     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0149-7634(96)00011-5     Document Type: Article

References (132)

1. 1 receptors: intracellular analysis of the actions of adenosine agonists and antagonists in rat hippocampal neurones. Brain Res. 546:1991;69-78.
2. Andiné P., Rudolphi K.A., Fredholm B.B., Hagberg H. Effect of propentofylline (HWA 285) on extracellular purines in CA1 of rat hippocampus during transient ischaemia. Br. J. Pharmac. 100:1990;814-818.
3. Banati R.B., Schubert P., Rothe G., Gehrmann J., Rudolphi K., Valet G., Kreutzberg G.W. Modulation of intracellular formation of reactive oxygen intermediates in peritoneal macrophages and microglia/brain macrophages by propentofylline. J. Cereb. Blood Flow Metab. 14:1994;145-149.
4. Berne R.M., Rubio R., Curnish R.R. Release of adenosine from ischemic brain. Circ. Res. 35:1974;262-271.
5. Boissard C.G., Lindner M.D., Gribkoff V.K. Hypoxia produces cell death in the rat hippocampus in the presence of an A1 adenosine receptor antagonist: an anatomical and behavioral study. Neurosci. 48:1992;807-812.
6. Bruns, R.F.; Lu, G.H.; Pugsley, T.A. Adenosine receptor subtypes: binding studies. In: Gerlach, E.; Becker, B.F., eds. Topics and Perspectives in Adenosine Research. Berlin: Springer; 1987; 59-73.
7. Buck L.T., Bickler P.E. Role of adenosine in NMDA receptor modulation in the cerebral cortex of an anoxia-tolerant turtle (Chrysemys picta belli). J. Exp. Biol. 198:1995;1621-1628.
8. Busto R., Globus M.T.-Y., Dietrich W.D., Valdes I., Santiso M., Ginsberg M.D. The increase in endogenous adenosine by adenosine deaminase inhibitor fails to protect against ischemia-induced neuronal damage. J. Cereb. Blood Flow Metab. 9:((Suppl.)):1989;S267.
9. Canhão P., de Mendonça A., Ribeiro J.A. 1,3-Dipropyl-8-cyclopentylxanthine attenuates the NMDA response to hypoxia in the rat hippocampus. Brain Res. 661:1994;265-273.
10. Chen Y., Graham D.I., Stone T.W. Release of endogenous adenosine and its metabolites by the activation of NMDA receptors in the rat hippocampus in vivo. Br. J. Pharmac. 106:1992;632-638.
11. Collis M.G., Hourani S.M.O. Adenosine receptor subtypes. Trends Pharmac. Sci. 14:1993;360-366.
12. Craig C.G., White T.D. N-methyl-D-aspartate- and non-N-methyl-D-aspartate-evoked adenosine release from rat cortical slices: Distinct purinergic sources and mechanisms of release. J. Neurochem. 60:1993;1073-1080.
13. Daly J.W. Adenosine receptors: Targets for future drugs. J. Med. Chem. 25:1982;197-207.
14. Daly, J.W. Mechanism of action of caffeine. In: Garattini, S., ed. Caffeine, coffee, and health. New York: Raven Press; 1993:97-150.
15. Danielisová V., Chavko M., Schubert P.H. Effect of propentofylline (HWA 285) on metabolic and functional recovery in the spinal cord after ischemia. Neuropharmacol. 33:1994;199-204.
16. Daval J.-L., Nehlig A., Nicolas F. Physiological and pharmacological properties of adenosine: therapeutic implications. Life Sci. 49:1991;1435-1453.
17. Daval J.-L., Nicolas F. Opposite effects of cyclohexyladenosine and theophylline on hypoxic damage in cultured neurons. Neurosci. Lett. 175:1994;114-116.
18. Deckert J., Gleiter C.H. Adenosinergic pharmaceuticals. Trends Pharmac. Sci. 10:1989;99-100.
19. Delaney S.M., Sutherland G.R., Peeling J., Geiger J.D. Failure of 2′-deoxycoformycin to protect against transient forebrain ischemia in rat. Neurosci. Lett. 149:1993;31-34.
20. DeLeo J., Schubert P., Kreutzberg G.W. Propentofylline (HWA 285) protects hippocampal neurons of the Mongolian gerbils against ischemic damage in the presence of an adenosine antagonist. Neurosci. Lett. 84:1988;307-311.
21. Dolphin A.C., Forda S.R., Scott R.H. Calcium-dependent currents in cultured rat dorsal root ganglion neurones are inhibited by an adenosine analogue. J. Physiol. (Lond.). 373:1986;47-61.
22. Dolphin A.C., Prestwich S.A. Pertussis toxin reverses adenosine inhibition of neuronal glutamate release. Nature. 316:1985;148-150.
23. Domanska-Janik K., Pylowa S., Zalewska T. Coupling of adenosine receptors to adenylate cyclase in postischemic rat brain. Cell. Signal. 5:1993;337-343.
24. Donaghy K.M., Scholfield C.N. Concentration dependence of adenosine and the protection of rat cortical neurones during anoxia. Brain Res. 656:1994;174-176.
25. Dragunow M., Faull R.L.M. Neuroprotective effects of adenosine. Trends. Pharmac. Sci. 9:1988;193-194.
26. Evans M.C., Swan J.H., Meldrum B.S. An adenosine analogue, 2-chloroadenosine, protects against long-term development of ischaemic cell loss in the rat hippocampus. Neurosci. Lett. 83:1987;287-292.
27. Fern R., Waxman S.G., Ransom B.R. Modulation of anoxic injury in CNS white matter by adenosine and interaction between adenosine and GABA. J. Neurophysiol. 72:1994;2609-2616.
28. Fitzgibbons J.C., Shah A.R., Park T.S., Gidday J.M. Caffeine blocks the cerebroprotective actions of preconditioning in the hypoxic-ischemic neonate. Soc. Neurosci. Abstr. 20:1994;618.
29. Fozard J.R., Carruthers A.M. Adenosine A3 receptors mediate hypotension in the angiotensin II supported circulation of the pithed rat. Br. J. Pharmac. 109:1993;3-7.
30. Fredholm B.B. Purinoceptors in the nervous system. Pharmac. Toxic. 76:1995;228-239.
31. Fredholm B.B., Abbrachio M.P., Burnstock G., Daly J.W., Harden T.K., Jacobson K.A., Leff P., Williams M. Nomenclature and classification of purinoceptors. Pharmac. Rev. 46:1994;143-156.
32. Fredholm B.B., Lindström K., Wallman-Johansson A. Propentofylline and other adenosine transport inhibitors increase the efflux of adenosine following electrical stimulation or metabolic stimulation of rat hippocampal slices. J. Neurochem. 62:1994;563-573.
33. Fredholm, B.B.; Lloyd, H.G.E. Sources of adenosine released from hippocampal slices following electrical and hypoxic/hypoglycemic stimulation. In: Dubyak, G.R.; Fedan, J. S., eds. Ann. N.Y. Acad. Sci. Vol. 603. Biological actions of extracellular ATP. New York: New York Academy of Sciences; 1990:497-499.
34. Geiger, J.D.; Fyda, D.M. Adenosine transport in nervous tissues. In: Stone, T., ed. Adenosine in the nervous system. London: Academic Press; 1991; 1-23.
35. Gidday J.M., Fitzgibbons J.C., Maceren R.G., Shah A.R., Shah N.R., Park T.S. Inhibition of adenosine deaminase with deoxycoformycin (DCF) potentiates preconditioning cerebro-protection in a perinatal rat model of ischemic tolerance. Soc. Neurosci. Abstr. 21:1995;513.
36. Gidday J.M., Fitzgibbons J.C., Shah A.R., Park T.S. Neuroprotection from ischemic brain injury by hypoxic preconditioning in the neonatal rats. Neurosci. Lett. 168:1994;221-224.
37. Ginsberg M.D., Pulsinelli W.A. The ischemic penumbra, injury thresholds, and the therapeutic window for acute stroke. Ann. Neurol. 36:1994;553-554.
38. Goldberg M.P., Monyer H., Weiss J.H., Choi D.W. Adenosine reduces cortical neuronal injury induced by oxygen or glucose deprivation in vitro. Neurosci. Lett. 89:1988;323-327.
39. Greene R.W., Haas H.L. The electrophysiology of adenosine in the mammalian central nervous system. Progr. Neurobiol. 36:1991;329-341.
40. Grome J.J., Rudolphi K., Harper A.M. Cerebrovascular effects of a xanthine derivative propentofylline (HWA 285). Drug Dev. Res. 5:1985;111-121.
41. Hagberg H., Andersson P., Lacarewicz J., Jacobson I., Butcher S., Sandberg M. Extracellular adenosine, inosine, hypoxanthine, and xanthine in relation to tissue nucleotides and purines in rat striatum during transient ischemia. J. Neurochem. 49:1987;227-231.
42. Héron A., Lasbennes F., Seylaz J. Adenosine modulation of amino acid release in rat hippocampus during ischemia and veratridine depolarization. Brain Res. 608:1993;27-32.
43. Héron A., Lekieffre D., Le Peillet E., Lasbennes F., Seylaz J., Plotkine M., Boulu R.G. Effects on an A1 adenosine receptor agonist on the neurochemical, behavioral and histochemical consequences of ischemia. Brain Res. 641:1994;217-224.
44. + channels in cerebral ischemic preconditioning. Proc. Natl Acad. Sci. USA. 92:1995;4666-4670.
45. Huber M., Kittner B., Hojer C., Fink G.R., Neveling M., Heiss W.-D. Effect of propentofylline on regional cerebral glucose metabolism in acute ischemic stroke. J. Cereb. Blood Flow Metab. 13:1993;526-530.
46. Hudlicka O., Komarek J., Wright A.J.A. The effect of a xanthine derivative. 1-(5-oxohexyl)-3-methyl-7-propylxanthine (HWA 285), on heart performance and regional blood flow in dogs and rabbits. Br. J. Pharmac. 72:1981;723-730.
47. Hylland P., Goran G.E., Lutz L.L. Time course of anoxia-induced increase in cerebral blood flow rate in turtles: evidence for a role of adenosine. J. Cereb. Blood Flow Metab. 14:1994;877-881.
48. 3 adenosine receptors: mediation of behavioral depressant effects. FEBS Lett. 336:1993;57-60.
49. 2 receptors in the rat brain. Brain Res. 484:1989;111-118.
50. 3H]CGS 21680. Eur. J. Pharmac. 168:1989;243-246.
51. Juurlink B.H.J., Sweeney M.I. Mechanisms that result in damage during and following cerebral ischemia. Neurosci. Biobehav. Rev. 21:1996;121-128.
52. Kano T., Katayama Y., Kawamata T., Hirota H., Tsubokawa T. Propentofylline administered by microdialysis attenuates ischemia-induced hippocampal damage but not excitatory amino acid release in gerbils. Brain Res. 641:1994;149-154.
53. Kasai H., Aosaki T. Modulation of Ca-channel current by an adenosine analog mediated by a GTP-binding protein in chick sensory neurons. Eur. J. Physiol. 414:1989;145-149.
54. 1 and calcium antagonist binding sites in the gerbil hippocampus following repeated brief ischemia. Brain Res. 553:1991;33-38.
55. Kato H., Liu Y., Araki T., Kogure K. Temporal profile of the effects of pretreatment with brief cerebral ischemia on the neuronal damage following secondary ischemic insult in the gerbil: cumulative damage and protective effects. Brain Res. 553:1991;238-242.
56. Kim Y.B., Park T.S., Gonzales E.R., Shah A.R., Noetzel M.J., Gidday J.M. Potentiation of interstitial adenosine with nitrobenzylthioinosine (NBTI) ameliorates delayed cortical hypoperfusion following global cerebral ischemia in the piglet. Soc. Neurosci. Abstr. 21:1995;1670.
57. Kirino T., Tsujita Y., Tamura A. Induced tolerance to ischemia in gerbil hippocampal neurons. J. Cereb. Blood Flow Metab. 11:1991;299-307.
58. Laudignon N., Farri E., Beharry K., Aranda J.V. Rapid effects of hypoxia on the cerebrospinal fluid levels of adenosine and related metabolites in newborn and one-month old piglets. Biol. Neonate. 59:1991;54-59.
59. 1 receptors. Brain Res. 609:1993;313-315.
60. Lee K.S., Tetzlaff W., Kreutzberg G.W. Rapid down regulation of hippocampal adenosine receptors following brief anoxia. Brain Res. 380:1986;155-158.
61. Lekieffre D., Calleberg J., Plotkine M., Allix M., Boulu R.G. Enhancement of endogenous excitatory amino acids by theophylline does not modify the behavioral and histochemical consequences of forebrain ischemia. Brain Res. 565:1991;353-357.
62. Lin Y., Phillis J.W. Deoxycoformycin and oxypurinol: protection against focal ischemic brain injury in the rat. Brain Res. 571:1992;272-280.
63. 3 adenosine receptor with widespread tissue distribution. Molec. Pharmac. 44:1993;524-532.
64. Liu Y., Kato H., Nakata H., Kogure K. Protection of rat hippocampus against ischemic neuronal damage by pretreatment with sublethal ischemia. Brain Res. 586:1992;121-124.
65. Lobner D., Choi D.W. Dipyridamole increases oxygen-glucose deprivation-induced injury in cortical cell culture. Stroke. 25:1994;2085-2090.
66. + and veratridine. J. Neurochem. 45:1985;791-797.
67. Marangos P.J. Adenosinergic approaches to stroke therapeutics. Med. Hypoth. 32:1990;45-49.
68. Marangos P.J., Boulenger J.P. Basic and clinical aspects of adenosinergic neuromodulation. Neurosci. Biobehav. Rev. 9:1985;421-430.
69. Matsumoto K., Graf R., Rosner G., Nobumitsu S., Heiss W.D. Flow thresholds for extracellular purine catabolite elevation in cat focal ischemia. Brain Res. 579:1992;309-314.
70. Mattson M.P. Neuroprotective signal transduction: relevance to stroke. Neurosci. Biobehav. Rev. 21:1996;193-206.
71. Mattson, M.P.; Barger, S.W. Programmed cell life: neuroprotective signal transduction and ischemic brain injury. In: Proceedings of the Nineteenth Princeton Conference (Butterworth, Stoneham, MA); 1995:271-290.
72. Meghji, P.V. Adenosine production and metabolism. In: Stone, T.; ed. Adenosine in the nervous system. London: Academic Press; 1991:25-42.
73. 1 adenosine receptor from guinea pig brain. Molec. Brain Res. 26:1994;143-155.
74. Meyerhof W., Müller-Brechlin R., Richter D. Molecular cloning of a novel putative G-protein coupled receptors expressed during rat spermiogenesis. FEBS Lett. 284:1991;155-160.
75. Miyashita K., Nakajima T., Ishikawa A., Miyatake T. An adenosine uptake blocker, propentofylline, reduces glutamate release in gerbil hippocampus following transient forebrain ischemia. Neurochem. Res. 17:1992;147-150.
76. Mogul D.J., Adams M.E., Fox A.P. Differential activation of adenosine receptors decreases N-type but potentiates P-type current in hippocampal CA3 neurons. Neuron. 10:1993;327-334.
77. Mori M., Nishizaki T., Okada Y. Protective effect of adenosine on the anoxic damage of hippocampal slice. Neurosci. 46:1992;301-307.
78. Morley P., Hogan M.J., Hakim A.M. Calcium-mediated mechanisms of ischemic injury and protection. Brain Pathol. 4:1994;37-47.
79. Nagasawa H., Araki T., Kogure K. Alteration of adenosine A1 receptor binding in the post ischaemic rat brain. Neuroreport. 5:1994;1453-1456.
80. Nagy J.I., Geiger J.D., Staines W.A. Adenosine deaminase and purinergic metabolism. Neurochem. Int. 16:1990;211-221.
81. Nilsson G.E., Lutz P.L. Adenosine release in the anoxic turtle brain: a possible mechanism for anoxic survival. J. Exp. Biol. 162:1992;345-351.
82. Nolte D., Lorenzen A., Lehr H.A., Zimmer F.J., Klotz K.N., Messner K. Reduction of postischemic leukocyte-endothelium interaction by adenosine A2 receptor. Naunyn Schm. Arch. Pharmac. 346:1992;234-237.
83. 3H]-1,3-dipropyl-8-cyclopentylxanthine in frog brain membranes. Br. J. Pharmacol. 109:1993;518-523.
84. 1 receptors in the gerbil hippocampus: changes in the receptor density after transient ischemia. Brain Res. 345:1985;406-408.
85. 1, and muscarinic bindings in rat hippocampus after transient ischemia. Stroke. 21:1990;771-776.
86. 1 binding sites after transient forebrain ischemia in the gerbil. Brain Res. 415:1987;309-322.
87. Park C.K., Rudolphi K.A. Antiischemic effects of propentofylline (HWA 285) against focal cerebral infarction in rats. Neurosci. Lett. 178:1994;235-238.
88. Park T.S., Gidday J.M. Effect of dipyridamole on cerebral extracellular adenosine level in vivo. J. Cereb. Blood Flow Metab. 10:1990;424-427.
89. Park T.S., Gonzales E.R., Maceren R.G., Shah A.R., Gidday J.M. Reduction in asphyxia-induced leukocyte adherence to piglet cerebral venules by pretreatment with superoxide dismutase (SOD) and catalase (CAT), or the adenosine agonist CGS 21680. Soc. Neurosci. Abstr. 21:1995;220.
90. Parkinson F.E., Rudolphi K.A., Fredholm B.B. Propentofylline: A nucleoside transport inhibitor with neuroprotective effects in cerebral ischemia. Gen. Pharmac. 25:1994;1053-1058.
91. Perez-Pinzon M.A., Lutz P.L., Sick T.J., Rosenthal M. Adenosine, a `retaliatory metabolite', promotes anoxia-tolerance in the turtle. J. Cereb. Blood Flow Metab. 13:1993;728-732.
92. Phillis J.W., O'Regan M.H. Deoxycoformycin antagonizes ischemia-induced neuronal degeneration. Brain Res. Bull. 22:1989;537-540.
93. Phillis J.W., O'Regan M.H., Walter G.A. Effects of deoxycoformycin on adenosine, inosine, hypoxanthine, xanthine and uric acid release from the hypoxemic rat cerebral cortex. J. Cereb. Blood Flow Metab. 8:1988;733-741.
94. Phillis J.W., Smith-Barbour M. The adenosine kinase inhibitor, 5-iodotubercidin, is not protective against cerebral ischemic injury in the gerbil. Life Sci. 53:1993;497-502.
95. Phillis J.W., Smith-Barbour M., Perkins L.M., O'Regan M.H. Characterization of glutamate, aspartate, and GABA release from ischemic rat cerebral cortex. Brain Res. Bull. 34:1994;457-466.
96. Phillis J.W., Walter G.A., Simpson R.E. Brain adenosine and transmitter amino acid release from the ischemic rat cerebral cortex: Effects of the adenosine deaminase inhibitor deoxycoformycin. J. Neurochem. 56:1991;644-650.
97. Phillis J.W., Wu P.H. Roles of adenosine and its nucleotides in central transmission. Progr. Neurobiol. 16:1981;187-239.
98. Roussel S., Pinard E., Seylaz J. Focal cerebral ischemia in chronic hypertension: no protection by (R)-phenylisopropyladenosine. Brain Res. 545:1991;171-174.
99. Rudolphi K.A., Schubert P., Parkinson F.E., Fredholm B.B. Neuroprotective role of adenosine in cerebral ischaemia. Trends Pharmac. Sci. 13:1992;439-445.
100. Rudolphi K.A., Schubert P., Parkinson F.E., Fredholm B.B. Adenosine and brain ischemia. Cerebrovasc. Brain Metab. Rev. 4:1992;346-369.
101. Salter M.W., DeKoninck Y., Henry J.L. Physiological roles for adenosine and ATP in synaptic transmission in the spinal dorsal horn. Progr. Neurobiol. 41:1993;125-156.
102. 3 adenosine receptor. Proc. Natl. Acad. Sci. USA. 90:1993;10,365-10,369.
103. 31P nuclear magnetic resonance spectroscopy. Arzneim-Forsch./Drug Res. 39:1989;886-889.
104. Sawynok J. Pharmacological rationale for the clinical use of caffeine. Drugs. 49:1995;37-50.
105. Sawynok J., Sweeney M.I. The role of purines in nociception. Neuroscience. 32:1989;557-569.
106. 2+ currents and synaptic transmission in cultured rat hippocampal pyramidal neurones. J. Physiol. (Lond.). 453:1991;373-393.
107. Schubert P., Rudolphi K.A., Fredholm B.B., Nakamura Y. Modulation of nerve and glial function by adenosine - role in the development of ischemic damage. Int. J. Biochem. 26:1994;1227-1236.
108. Sciotti V., Roche F., Grabb M., Van Wylen D.G.L. Adenosine receptor blockade augments interstitial fluid levels of excitatory amino acids during cerebral ischemia. J. Cereb. Blood Flow Metab. 12:1992;646-655.
109. Siesjö B.K., Bengtsson F. Calcium fluxes, calcium antagonists and calcium-related pathology in brain ischemia, hypoglycemia and spreading depression: a unifying hypothesis. J. Cereb. Blood Flow Metab. 9:1989;155-185.
110. Simpson R.E., O'Regan M.H., Perkins L.M., Phillis J.W. Excitatory transmitter amino acid release from the ischemic rat cerebral cortex: effects of adenosine receptor agonists and antagonists. J. Neurochem. 58:1992;1683-1690.
111. Snyder S.H. Adenosine as a neuromodulator. Ann. Rev. Neurosci. 8:1985;103-124.
112. Sollevi A. Cardiovascular effects of adenosine in man; possible clinical implications. Progr. Neurobiol. 27:1986;319-349.
113. Stefanovich V. Effect of propentofylline on cerebral metabolism of rats. Drug Dev. Res. 6:1985;327-338.
114. Sweeney M.I. Activation of adenosine receptors protects neurons from ischemia-induced death. Soc. Neurosci. Abstracts. 20:1994;1042.
115. Sweeney, M.I.; Arneson, D.S. Desensitization of adenosine receptors during brain hypoxia limits the neuroprotective effects of adenosine. Can. J. Physiol. Pharmac. 74:Axxxiv-xxxv, 1996.
116. Sweeney M.I., Logan M. Endogenous adenosine protects neurons but not astrocytes from hypoxic cell death. Proc. Can. Fed. Biol. Soc. 38:1995;58.
117. Sweeney M.I., White T.D., Sawynok J. Morphine-evoked release of adenosine from the spinal cord occurs via a nucleoside carrier with differential sensitivity to dipyridamole and nitrobenzylthioinosine. Brain Res. 614:1993;301-307.
118. Sweeney M.I., Yager J.Y., Walz W., Juurlink B.H.J. Cellular mechanisms involved in brain ischemia. Can. J. Physiol. Pharmac. 73:1995;1525-1535.
119. Ultsch G.R., Jackson D.C. Long-term submergence at 3°C of the turtle Chrysemys picta bellii, in normoxic and severely hypoxic water. I. Survival, gas exchange and acid-base status. J. Exp. Biol. 96:1982;11-28.
120. Van Wylen D.G.L., Park T.S., Rubio R., Berne R.M. Increases in cerebral interstitial fluid adenosine concentration during hypoxia, local potassium infusion, and ischemia. J. Cereb. Blood Flow Metab. 6:1986;522-528.
121. 3 receptor stimulation on seizures in mice. Eur. J. Pharmac. 275:1995;23-29.
122. 1 receptor agonist or antagonist in cerebral ischemia. Eur. J. Pharmac. 256:1994;161-167.
123. 3 receptor stimulation and cerebral ischemia. Eur. J. Pharmac. 263:1994;59-67.
124. Von Lubitz D.K.E.G., Marangos P.J. Cerebral ischemia in gerbils: postischemic administration of cyclohexyl adenosine and 8-sulfophenyl-theophylline. J. Molec. Neurosci. 2:1990;53-59.
125. White, T.D.; Hoehn, K. Release of adenosine and ATP from nervous tissue. In: Stone, T., ed. Adenosine in the nervous system. London: Academic Press; 1991:173-195.
126. White, T.D.; MacDonald, W.F. Neural release of ATP and adenosine. In: Dubyak, G.R.; Fedan, J.S.; eds. Ann. N.Y. Acad. Sci. Vol. 603. Biological actions of extracellular ATP. New York: New York Academy of Sciences; 1990:287-299.
127. Wu L., Saggau P. Adenosine inhibits evoked synaptic transmission primarily by reducing presynaptic calcium influx in area CA1 of the hippocampus. Neuron. 12:1994;1139-1148.
128. Wu P.H., Phillis J.W. Uptake by central nervous tissues as a mechanism for the regulation of extracellular adenosine concentrations. Neurochem. Int. 6:1984;613-632.
129. 2+ channels by adenosine autoreceptors. Nature. 365:1993;256-258.
130. Zeng Y.C., Domenici M.R., Frank C., Sagratella S., de Carolis A.S. Effects of adenosinergic drugs on hypoxia-induced electrophysiological changes in rat hippocampal slices. Life Sci. 51:1992;1073-1082.
131. Zhou J., Meno J.R., Hsu S.S.-F., Winn H.R. Effects of theophylline and cyclohexyladenosine on brain injury following normo- and hyperglycemic ischemia: a histopathologic study in the rat. J. Cereb. Blood Flow Metab. 14:1994;166-173.
132. 3 adenosine receptors. Proc. Natl. Acad. Sci. USA. 89:1992;7432-7436.